Agneta Andersson‐Ellström

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · British Journal of Cancer · 2006 · 804 citations · Full text

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

Sven‐Eric Olsson, Luisa L. Villa, Ronaldo Lúcio Rangel Costa et al. · Vaccine · 2007 · 454 citations

Vaccination, Vaccine Development, L1 Virus-like Particle +8

Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study

Björn Strander, Agneta Andersson‐Ellström, Ian Milsom et al. · BMJ · 2007 · 178 citations · Full text

Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program

Björn Strander, Agneta Andersson‐Ellström, Ian Milsom et al. · Cancer · 2007 · 109 citations · Full text

Comparison of Development of Serum Antibodies to HPV16 and HPV33 and Acquisition of Cervical HPV DNA Among Sexually Experienced and Virginal Young Girls

Agneta Andersson‐Ellström, Joakim Dillner, B Hagmar et al. · Sexually Transmitted Diseases · 1996 · 96 citations